| Domain |
Quality Indicator |
Facility |
State |
Facility rank
(#1 is best) |
| For the Quality Indicators below, a lower percentage is better. |
| Psychosocial |
Worsening or serious resident behavior problems (LS) |
10.2% |
8.4% |
235 of
326 |
| Psychosocial |
Prevalence of depressive symptoms (LS) |
4.4% |
4.1% |
212 of
325 |
| Quality of Life |
Prevalence of physical restraints (LS) |
0.0% |
0.0% |
1 of
326 |
| Continence |
Worsening or serious bowel incontinence (LS) |
39.7% |
30.5% |
266 of
326 |
| Continence |
Worsening or serious bladder incontinence (LS) |
46.9% |
29.9% |
292 of
326 |
| Continence |
Prevalence of occasional to full bowel incontinence without a toileting plan (LS) |
100.0% |
93.9% |
161 of
314 |
| Continence |
Prevalence of occasional to full bladder incontinence without a toileting plan (LS) |
88.6% |
84.8% |
147 of
318 |
| Continence |
Prevalence of indwelling catheter (LS) |
6.0% |
2.3% |
298 of
326 |
| Infections |
Prevalence of urinary tract infections (LS) |
7.0% |
2.9% |
303 of
326 |
| Infections |
Prevalence of infections (LS) |
3.1% |
2.4% |
231 of
324 |
| Accidents |
Percent of residents experiencing one or more falls with major injury (LS) |
1.3% |
0.7% |
274 of
326 |
| Nutrition |
Prevalence of unexplained weight loss (LS) |
4.3% |
4.3% |
185 of
326 |
| Skin Care |
Prevalence of pressure sores in high risk residents (LS) |
6.6% |
5.1% |
235 of
322 |
| Psychotropics |
Prevalence of anti-psychotics without a diagnosis of psychosis (LS) |
7.0% |
9.0% |
150 of
321 |
| Functioning |
Worsening or serious functional dependence (LS) |
n/a |
|
n/a of
0 |
| Functioning |
Worsening or serious mobility dependence (LS) |
n/a |
|
n/a of
0 |
| Functioning |
Worsening or serious range of motion limitation (LS) |
11.5% |
13.2% |
170 of
323 |
| Pain |
Percent of residents who self-report moderate to severe pain (LS) |
17.1% |
14.7% |
206 of
325 |
| For the Quality Indicators below, a higher percentage is better. |
| Functioning |
Walking as well or better than on a previous assessment (LS) |
n/a |
|
n/a of
0 |
| (Date range:
October 1, 2023 to September 30, 2024) |
Contact Us
